Research Lines in the Polymer Therapeutics Laboratory

Currently Funded Projects

PROJECT TITLE: MITONano: Grants from the Scientific Foundation of the Spanish Association Against Cancer (AECC General Projects; Ref: PRYGN259257VICE). Title: Targeting Mitochondrial Vulnerabilities with Nanomedicines for the Treatment of Peritoneal Carcinomatosis. LENGTH: 1/11/2025-30/10/2029 PI: María J. Vicent

PROJECT TITLE: NanoERT: nano-delivery platform for Enzyme Replacement Therapy in Parkinson's and Gaucher's disease. Funding agency: "la Caixa" Banking Foundation Caixa Impulse Innovation 2024 Call. LENGTH: 1/11/2024-30/04/2026. Coordinator: Julia Lorenzo (UAB). Co-PIs: Marta Martínez and María J Vicent.

PROJECT TITLE: PINT: Precision ImmuneNanoTherapy targeting tumor-immune-stroma interactions against pancreatic cancer (HR24-00968) Funding agency: Health Foundation La Caixa. LENGTH: 1/11/2024-30/10/2027. Coordinator: MJ Vicent, PI: H Florindo, R. Satchi-Fainaro

PROJECT TITLE: Point2Mets: A Multimodal Precision Polypeptide-based Nanoplatform to Treat and Monitor Metastatic Castration Resistance PCa. AEI Plan Nacional I+D 2023. Ref. PID2023-152459OB-I00. LENGTH: 1/09/2024-31/08/2027.PI: María J. Vicent co-PI: A. Armiñán.

PROJECT TITLE: ASPIRE: Grants from the Scientific Foundation of the Spanish Association Against Cancer AECC 70% Survivorship Challenge -Call 2024. Title: Neoadjuvant-adjuvant immunotherapy to improve survival in hepatocellular carcinoma. Team Coordinators: Josep M Llovet (Fundació de Recerca Clínic Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) Hospital Clinic Barcelona (HCB) Barcelona and Xosé R. Bustelo (Centro de Investigación del Cáncer (CIC), Salamanca). MJ Vicent WP Leader and member of Steering Committee.

PROJECT TITLE: NATPRIME: Effective Delivery of Nucleic Acid Therapeutics via Designed Nanocarriers (HORIZON-MSCA-2023-DN01. Proposal n.101168881) Funding Agency: Horizon Europe MSCA. LENGTH: 2024-2027. PIs: Coordinator: R. Bezer (Univ Warwick, UK) MJVicent PI Partner at CIPF.

PROJECT TITLE: UNLOOC. HORIZON-KDT-JU-2023-1-IA-Topic-1 — General according to ECS-SRIA 2022 (IA) Type of Action: HORIZON JU Innovation Actions. Proposal number: 101132028. 02/24-02/27. Coordinator: Juho Vuononvirta Microfluidic Chipshop GMBH. MJV PI Partner at CIPF

PROJECT TITLE: Cells2Spine: Spatial Transcriptomics and Cell Communication Models applied to tissue regeneration and treatment in Spinal Cord Injury with Precision Nanomedicine. Prometeo Program CIPROM/2022/25. Generalitat Valenciana, 09/23-09/27. Coordinator: Ana Conesa (CSIC)

PROJECT TITLE: IMPULSE: IMPROVING USER EXPERIENCE, LONG-TERM SUSTAINABILITY, AND SERVICES OF EU-OPENSCREEN. FUNDING AGENCY: Horizon Europe 101132028 PRINCIPAL Coordinator: EU-OPENSCREEN ERIC. Duration: 01/03/24 – 28/02/27

PROJECT TITLE: MultiSMART. Multi-component Soft Materials Advanced Research Training Network. FUNDING AGENCY: HORIZON-MSCA-2021-DN-01. Grant agreement ID: 101072585. 01/01/23 - 31/12/26. Coordinator: UB (Universite de Bordeaux, France).

PROJECT TITLE: Polymer Therapeutics for pediatric solid tumors (PT4PST). FUNDING AGENCY: AECC (Ayuda Investigador Talento AECC 2021). PI: Dr. Inmaculada Conejos-Sánchez

PROJECT TITLE: HERA. Hydrogels as tools for the development of Long-term release antiemetics. Public-private collaborative projects. AEI. Plan de Recuperación, Transformación y Resiliencia. Ref. CPP2022-010119. Laboratorios Rovi:CIPF. PI: MJ Vicent 01/12/23- 30/09/26.

PROJECT TITLE: Beca Santiago Grisolía FUNDING AGENCY: Conselleria d’educació. Generalitat Valenciana (CIGRIS/2021/100) LENGTH: 16/09/2022 - 15/09/2026. PI: Dr. M. J. Vicent.

PROJECT TITLE: MULTISMART-Multi-component Soft Materials Advanced Research Training Network. HORIZON-MSCA-2021-DN-01-01 Project ID 101072585. 101072585. Coordinator André Del Guerzo (univ Bordeaux, France). (MJVicent Partner at CIPF). 01/01/2023-31/12/2026.